Varian Receives FDA Breakthrough Device Designation For Embozene® Microspheres For Genicular Artery Embolization For Symptomatic Knee Osteoarthritis

/PRNewswire/ -- Varian, a Siemens Healthineers company, announced today that the U.S. Food and Drug Administration (FDA) has granted the company Breakthrough...

Related Keywords

United States ,Lynne Tran ,Siemens Healthineers ,Frank Facchini ,Siddharth Padia ,Santa Monica ,Prnewswire Varian ,World Health Care Resource Utilization ,Breakthrough Device Program ,Corporate Communications ,David Geffen School Of Medicine ,Varian Interventional Solutions ,Drug Administration ,Breakthrough Device Designation ,Interventional Radiology ,David Geffen School ,Varian Interventional ,Device Program ,Intelligent Cancer Care ,States Bone ,Joint Initiative ,Musculoskeletal Diseases ,Framingham Osteoarthritis ,Costs Among ,Knee Osteoarthritis Compared ,Clinicoecon Outcomes ,Ovarian ,